Leonard patent opposition analysis

The comprehensive analysis of Leonard opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Leonard

Patent NumberTitleApplicantOpposition DateOpposition Company
Extended, High Dose Vegf Antagonist Regimens For Treatment Of Angiogenic Eye DisordersBAYER HEALTHCAREJun 2, 2026KILBURN & STRODE
Liquid Composition Comprising Vegf AntagonistSAMSUNG BIOEPISFeb 16, 2026KILBURN & STRODE
ImmunoconjugatesTHE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITYSep 30, 2025STRAWMAN
Engineered Gamma Delta T-CellsADICET THERAPEUTICSSep 25, 2025STRAWMAN
Sorting With Counter Selection Using Sequence Similar PeptidesIMMATICSMay 28, 2025STRAWMAN
Non-Invasive Determination Of Methylome Of Tumor From PlasmaTHE CHINESE UNIVERSITY OF HONG KONGApr 30, 2025STRAWMAN
Chimeric Antigen Receptor (Car) T Cells As Therapeutic Interventions For Auto- And Allo-ImmunityREGENTS OF THE UNIVERSITY OF MINNESOTAApr 2, 2025STRAWMAN
Large-Scale Production Of Soluble HyaluronidaseHALOZYMEMar 5, 2025STRAWMAN
Methods And Compositions For Editing RnasEDIGENEMay 13, 2024KILBURN & STRODE
Identifying Patient Response To S1P Receptor Modulator AdministrationNOVARTISSep 20, 2023KILBURN & STRODE

Top companies who are the clients of Leonard